 | • レポートコード：GIR-107A08969 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、結核診断・治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。結核診断・治療の種類別市場規模（皮膚検査、実験室検査）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・結核診断・治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Cepheid Inc、Becton Dickinson、Hain LifeSciences、Abbott Laboratories、Alere, Inc、Roche AG、Hologic Corporation、bioMerieux、Sanofi、QIAGEN、Akonni Biosystems, Inc.、Epistem Holdings Plc、Gen-Probe Inc.、EIKEN Chemical、Thermo Fisher Scientific, Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：皮膚検査、実験室検査 ・用途別分析2016年-2026年：病院、クリニック、その他 ・結核診断・治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・結核診断・治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・結核診断・治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・結核診断・治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・結核診断・治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tuberculosis Diagnostics and Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Tuberculosis Diagnostics and Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Tuberculosis Diagnostics and Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Tuberculosis Diagnostics and Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Skin Testing
Laboratory Testing
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by players, this report covers
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics and Treatment
1.2 Classification of Tuberculosis Diagnostics and Treatment by Type
1.2.1 Overview: Global Tuberculosis Diagnostics and Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type in 2020
1.2.3 Skin Testing
1.2.4 Laboratory Testing
1.3 Global Tuberculosis Diagnostics and Treatment Market by Application
1.3.1 Overview: Global Tuberculosis Diagnostics and Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tuberculosis Diagnostics and Treatment Market Size & Forecast
1.5 Global Tuberculosis Diagnostics and Treatment Market Size and Forecast by Region
1.5.1 Global Tuberculosis Diagnostics and Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Tuberculosis Diagnostics and Treatment Market Size by Region, (2016-2021)
1.5.3 North America Tuberculosis Diagnostics and Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Tuberculosis Diagnostics and Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Tuberculosis Diagnostics and Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis Diagnostics and Treatment Market Drivers
1.6.2 Tuberculosis Diagnostics and Treatment Market Restraints
1.6.3 Tuberculosis Diagnostics and Treatment Trends Analysis
2 Company Profiles
2.1 Cepheid Inc
2.1.1 Cepheid Inc Details
2.1.2 Cepheid Inc Major Business
2.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Product and Solutions
2.1.4 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Cepheid Inc Recent Developments and Future Plans
2.2 Becton Dickinson
2.2.1 Becton Dickinson Details
2.2.2 Becton Dickinson Major Business
2.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Product and Solutions
2.2.4 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Becton Dickinson Recent Developments and Future Plans
2.3 Hain LifeSciences
2.3.1 Hain LifeSciences Details
2.3.2 Hain LifeSciences Major Business
2.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Product and Solutions
2.3.4 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Hain LifeSciences Recent Developments and Future Plans
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Product and Solutions
2.4.4 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Abbott Laboratories Recent Developments and Future Plans
2.5 Alere, Inc
2.5.1 Alere, Inc Details
2.5.2 Alere, Inc Major Business
2.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Product and Solutions
2.5.4 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Alere, Inc Recent Developments and Future Plans
2.6 Roche AG
2.6.1 Roche AG Details
2.6.2 Roche AG Major Business
2.6.3 Roche AG Tuberculosis Diagnostics and Treatment Product and Solutions
2.6.4 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche AG Recent Developments and Future Plans
2.7 Hologic Corporation
2.7.1 Hologic Corporation Details
2.7.2 Hologic Corporation Major Business
2.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Product and Solutions
2.7.4 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Hologic Corporation Recent Developments and Future Plans
2.8 bioMerieux
2.8.1 bioMerieux Details
2.8.2 bioMerieux Major Business
2.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Product and Solutions
2.8.4 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 bioMerieux Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Tuberculosis Diagnostics and Treatment Product and Solutions
2.9.4 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 QIAGEN
2.10.1 QIAGEN Details
2.10.2 QIAGEN Major Business
2.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Product and Solutions
2.10.4 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 QIAGEN Recent Developments and Future Plans
2.11 Akonni Biosystems, Inc.
2.11.1 Akonni Biosystems, Inc. Details
2.11.2 Akonni Biosystems, Inc. Major Business
2.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product and Solutions
2.11.4 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Akonni Biosystems, Inc. Recent Developments and Future Plans
2.12 Epistem Holdings Plc
2.12.1 Epistem Holdings Plc Details
2.12.2 Epistem Holdings Plc Major Business
2.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product and Solutions
2.12.4 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Epistem Holdings Plc Recent Developments and Future Plans
2.13 Gen-Probe Inc.
2.13.1 Gen-Probe Inc. Details
2.13.2 Gen-Probe Inc. Major Business
2.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product and Solutions
2.13.4 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Gen-Probe Inc. Recent Developments and Future Plans
2.14 EIKEN Chemical
2.14.1 EIKEN Chemical Details
2.14.2 EIKEN Chemical Major Business
2.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Product and Solutions
2.14.4 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 EIKEN Chemical Recent Developments and Future Plans
2.15 Thermo Fisher Scientific, Inc
2.15.1 Thermo Fisher Scientific, Inc Details
2.15.2 Thermo Fisher Scientific, Inc Major Business
2.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product and Solutions
2.15.4 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Thermo Fisher Scientific, Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tuberculosis Diagnostics and Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Tuberculosis Diagnostics and Treatment Players Market Share
3.2.2 Top 10 Tuberculosis Diagnostics and Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Tuberculosis Diagnostics and Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Tuberculosis Diagnostics and Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2016-2021)
5.2 Tuberculosis Diagnostics and Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2026)
6.2 North America Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2026)
6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Country
6.3.1 North America Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2026)
6.3.2 United States Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2026)
7.2 Europe Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2026)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Country
7.3.1 Europe Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2026)
7.3.2 Germany Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
7.3.3 France Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region
8.3.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Region (2016-2026)
8.3.2 China Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
8.3.5 India Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2026)
9.2 South America Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2026)
9.3 South America Tuberculosis Diagnostics and Treatment Market Size by Country
9.3.1 South America Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country
10.3.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Tuberculosis Diagnostics and Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Tuberculosis Diagnostics and Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Tuberculosis Diagnostics and Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Tuberculosis Diagnostics and Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Tuberculosis Diagnostics and Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Region (2021-2026)
Table 6. Cepheid Inc Corporate Information, Head Office, and Major Competitors
Table 7. Cepheid Inc Major Business
Table 8. Cepheid Inc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 9. Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 11. Becton Dickinson Major Business
Table 12. Becton Dickinson Tuberculosis Diagnostics and Treatment Product and Solutions
Table 13. Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Hain LifeSciences Corporate Information, Head Office, and Major Competitors
Table 15. Hain LifeSciences Major Business
Table 16. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product and Solutions
Table 17. Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Abbott Laboratories Major Business
Table 20. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product and Solutions
Table 21. Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Alere, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Alere, Inc Major Business
Table 24. Alere, Inc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 25. Alere, Inc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche AG Corporate Information, Head Office, and Major Competitors
Table 27. Roche AG Major Business
Table 28. Roche AG Tuberculosis Diagnostics and Treatment Product and Solutions
Table 29. Roche AG Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Hologic Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Hologic Corporation Major Business
Table 32. Hologic Corporation Tuberculosis Diagnostics and Treatment Product and Solutions
Table 33. Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. bioMerieux Corporate Information, Head Office, and Major Competitors
Table 35. bioMerieux Major Business
Table 36. bioMerieux Tuberculosis Diagnostics and Treatment Product and Solutions
Table 37. bioMerieux Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sanofi Corporate Information, Head Office, and Major Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Tuberculosis Diagnostics and Treatment Product and Solutions
Table 41. Sanofi Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 43. QIAGEN Major Business
Table 44. QIAGEN Tuberculosis Diagnostics and Treatment Product and Solutions
Table 45. QIAGEN Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Akonni Biosystems, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Akonni Biosystems, Inc. Major Business
Table 48. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product and Solutions
Table 49. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Epistem Holdings Plc Corporate Information, Head Office, and Major Competitors
Table 51. Epistem Holdings Plc Major Business
Table 52. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 53. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Gen-Probe Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Gen-Probe Inc. Major Business
Table 56. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product and Solutions
Table 57. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. EIKEN Chemical Corporate Information, Head Office, and Major Competitors
Table 59. EIKEN Chemical Major Business
Table 60. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product and Solutions
Table 61. EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Thermo Fisher Scientific, Inc Corporate Information, Head Office, and Major Competitors
Table 63. Thermo Fisher Scientific, Inc Major Business
Table 64. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product and Solutions
Table 65. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Tuberculosis Diagnostics and Treatment Revenue (USD Million) by Players (2019-2021)
Table 67. Global Tuberculosis Diagnostics and Treatment Revenue Share by Players (2019-2021)
Table 68. Breakdown of Tuberculosis Diagnostics and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Tuberculosis Diagnostics and Treatment Players Head Office, Products and Services Provided
Table 70. Tuberculosis Diagnostics and Treatment Mergers & Acquisitions in the Past Five Years
Table 71. Tuberculosis Diagnostics and Treatment New Entrants and Expansion Plans
Table 72. Global Tuberculosis Diagnostics and Treatment Revenue (USD Million) by Type (2016-2021)
Table 73. Global Tuberculosis Diagnostics and Treatment Revenue Share by Type (2016-2021)
Table 74. Global Tuberculosis Diagnostics and Treatment Revenue Forecast by Type (2021-2026)
Table 75. Global Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2021)
Table 76. Global Tuberculosis Diagnostics and Treatment Revenue Forecast by Application (2021-2026)
Table 77. North America Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Tuberculosis Diagnostics and Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Tuberculosis Diagnostics and Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Tuberculosis Diagnostics and Treatment Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Tuberculosis Diagnostics and Treatment Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Tuberculosis Diagnostics and Treatment Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Tuberculosis Diagnostics and Treatment Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Tuberculosis Diagnostics and Treatment Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Tuberculosis Diagnostics and Treatment Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Tuberculosis Diagnostics and Treatment Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Tuberculosis Diagnostics and Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Tuberculosis Diagnostics and Treatment Picture
Figure 2. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type in 2020
Figure 3. Skin Testing
Figure 4. Laboratory Testing
Figure 5. Tuberculosis Diagnostics and Treatment Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Tuberculosis Diagnostics and Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Tuberculosis Diagnostics and Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Region in 2020
Figure 13. North America Tuberculosis Diagnostics and Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Tuberculosis Diagnostics and Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Tuberculosis Diagnostics and Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Tuberculosis Diagnostics and Treatment Market Drivers
Figure 19. Tuberculosis Diagnostics and Treatment Market Restraints
Figure 20. Tuberculosis Diagnostics and Treatment Market Trends
Figure 21. Cepheid Inc Recent Developments and Future Plans
Figure 22. Becton Dickinson Recent Developments and Future Plans
Figure 23. Hain LifeSciences Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Alere, Inc Recent Developments and Future Plans
Figure 26. Roche AG Recent Developments and Future Plans
Figure 27. Hologic Corporation Recent Developments and Future Plans
Figure 28. bioMerieux Recent Developments and Future Plans
Figure 29. Sanofi Recent Developments and Future Plans
Figure 30. QIAGEN Recent Developments and Future Plans
Figure 31. Akonni Biosystems, Inc. Recent Developments and Future Plans
Figure 32. Epistem Holdings Plc Recent Developments and Future Plans
Figure 33. Gen-Probe Inc. Recent Developments and Future Plans
Figure 34. EIKEN Chemical Recent Developments and Future Plans
Figure 35. Thermo Fisher Scientific, Inc Recent Developments and Future Plans
Figure 36. Global Tuberculosis Diagnostics and Treatment Revenue Share by Players in 2020
Figure 37. Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Tuberculosis Diagnostics and Treatment Revenue Market Share in 2020
Figure 39. Global Top 10 Players Tuberculosis Diagnostics and Treatment Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Tuberculosis Diagnostics and Treatment Revenue Share by Type in 2020
Figure 42. Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Type (2021-2026)
Figure 43. Global Tuberculosis Diagnostics and Treatment Revenue Share by Application in 2020
Figure 44. Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Application (2021-2026)
Figure 45. North America Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2016-2026)
Figure 46. North America Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2016-2026)
Figure 47. North America Tuberculosis Diagnostics and Treatment Revenue Market Share by Country (2016-2026)
Figure 48. United States Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2016-2026)
Figure 52. Europe Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2016-2026)
Figure 53. Europe Tuberculosis Diagnostics and Treatment Revenue Market Share by Country (2016-2026)
Figure 54. Germany Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Market Share by Region (2016-2026)
Figure 62. China Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2016-2026)
Figure 69. South America Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2016-2026)
Figure 70. South America Tuberculosis Diagnostics and Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Tuberculosis Diagnostics and Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の結核治療市場 2021：企業別、地域別、種類・用途別 The Tuberculosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界のDNA検査/診断市場 2021：企業別、地域別、種類・用途別 The DNA Testing/Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の呼吸器疾患検査/診断市場 2021：企業別、地域別、種類・用途別 The Respiratory Disease Testing/Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の自己検査診断市場 2021：企業別、地域別、種類・用途別 The Self Testing Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の体外診断薬（IVD）・実験室開発自己免疫疾患検査市場 2021：企業別、地域別、種類・用途別 The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and glob…